Somatic activation of the K-ras oncogene causes early onset lung cancer in mice

Area of Science:

• Oncology
• Genetics
• Molecular Biology

Background:

• Ras gene mutations, particularly K-ras, are prevalent in human cancers, affecting approximately 30% of tumors.
• K-ras is the most frequently mutated ras gene family member in various cancers, including pancreatic, colon, and lung adenocarcinomas.

Purpose of the Study:

• To develop a novel mouse tumor model accurately reflecting spontaneous K-ras oncogene activation in human cancers.
• To investigate the interplay between oncogenic K-ras and the p53 tumor suppressor gene in a preclinical setting.

Main Methods:

• Utilized a new gene targeting strategy to create mouse strains with oncogenic K-ras alleles activated by spontaneous recombination.
• Examined the impact of germline mutations in the p53 tumor suppressor gene on tumor development in K-ras mutant mice.

Main Results:

• Mice engineered with oncogenic K-ras mutations exhibited a high predisposition to developing a spectrum of tumors.
• Lung cancer was the predominant tumor type observed, often with early onset.
• Co-mutation with p53 alterations influenced tumor development, mirroring human cancer genetics.

Conclusions:

• The developed mouse model effectively recapitulates spontaneous oncogene activation and tumor formation seen in human K-ras-driven cancers.
• This model provides a valuable preclinical tool for studying K-ras-driven tumorigenesis and evaluating therapeutic strategies, especially in conjunction with p53 status.